HSBC Downgrades AstraZeneca (AZN:LN) (AZN) to Hold

July 13, 2026 2:24 AM

HSBC analyst Rajesh Kumar downgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Buy to Hold with a price target of GBP137.50 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found